| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.144 | |
| histone modification | GO:0016570 | 159 | 0.090 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.087 | |
| gene silencing | GO:0016458 | 38 | 0.086 | |
| chromatin modification | GO:0016568 | 187 | 0.084 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.080 | |
| male gamete generation | GO:0048232 | 285 | 0.074 | |
| chromatin organization | GO:0006325 | 206 | 0.066 | |
| dna metabolic process | GO:0006259 | 303 | 0.057 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.051 | |
| rna 3 end processing | GO:0031123 | 20 | 0.048 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.043 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.042 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.041 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.041 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.041 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.040 | |
| spermatid differentiation | GO:0048515 | 115 | 0.040 | |
| axonogenesis | GO:0007409 | 274 | 0.039 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.039 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.037 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.036 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.034 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.032 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.032 | |
| mrna processing | GO:0006397 | 63 | 0.031 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.031 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.031 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.030 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.030 | |
| amine metabolic process | GO:0009308 | 45 | 0.030 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.030 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.030 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.029 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.029 | |
| circadian rhythm | GO:0007623 | 114 | 0.028 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.028 | |
| developmental maturation | GO:0021700 | 193 | 0.028 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.027 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.027 | |
| rhythmic process | GO:0048511 | 174 | 0.027 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.027 | |
| protein catabolic process | GO:0030163 | 221 | 0.027 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.026 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.026 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.026 | |
| neuron death | GO:0070997 | 154 | 0.025 | |
| protein maturation | GO:0051604 | 176 | 0.025 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.025 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.025 | |
| spermatid development | GO:0007286 | 108 | 0.024 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.024 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.024 | |
| spermatogenesis | GO:0007283 | 284 | 0.024 | |
| tube closure | GO:0060606 | 91 | 0.024 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.024 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.024 | |
| respiratory tube development | GO:0030323 | 167 | 0.023 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.023 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.023 | |
| tube formation | GO:0035148 | 140 | 0.023 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.023 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.023 | |
| cytokine production | GO:0001816 | 319 | 0.023 | |
| gland development | GO:0048732 | 330 | 0.022 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.022 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.022 | |
| cellular homeostasis | GO:0019725 | 240 | 0.022 | |
| lung development | GO:0030324 | 164 | 0.021 | |
| maintenance of location | GO:0051235 | 89 | 0.021 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.021 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.021 | |
| camera type eye development | GO:0043010 | 266 | 0.021 | |
| protein processing | GO:0016485 | 163 | 0.021 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.021 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.020 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.020 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.020 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.020 | |
| oogenesis | GO:0048477 | 56 | 0.020 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.020 | |
| neural tube formation | GO:0001841 | 108 | 0.019 | |
| organelle localization | GO:0051640 | 179 | 0.019 | |
| neural tube development | GO:0021915 | 160 | 0.019 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.019 | |
| phagocytosis | GO:0006909 | 66 | 0.018 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.018 | |
| regulation of neuron death | GO:1901214 | 134 | 0.018 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.018 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.018 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.018 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.018 | |
| rna processing | GO:0006396 | 105 | 0.018 | |
| respiratory system development | GO:0060541 | 190 | 0.018 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.018 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.017 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.017 | |
| epidermis development | GO:0008544 | 187 | 0.017 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.017 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.017 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.017 | |
| response to nutrient levels | GO:0031667 | 109 | 0.017 | |
| response to oxidative stress | GO:0006979 | 123 | 0.017 | |
| compound eye development | GO:0048749 | 1 | 0.017 | |
| neuron projection extension | GO:1990138 | 64 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.017 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.016 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.016 | |
| cell maturation | GO:0048469 | 127 | 0.016 | |
| dendrite development | GO:0016358 | 115 | 0.016 | |
| mrna metabolic process | GO:0016071 | 84 | 0.016 | |
| germ cell development | GO:0007281 | 185 | 0.016 | |
| multicellular organism growth | GO:0035264 | 161 | 0.016 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.016 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.016 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.016 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.016 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.015 | |
| innate immune response | GO:0045087 | 157 | 0.015 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.015 | |
| placenta development | GO:0001890 | 140 | 0.015 | |
| primary neural tube formation | GO:0014020 | 95 | 0.015 | |
| forebrain development | GO:0030900 | 302 | 0.015 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.015 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.015 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.015 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.014 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.014 | |
| skin development | GO:0043588 | 220 | 0.014 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.014 | |
| tissue homeostasis | GO:0001894 | 115 | 0.014 | |
| neural tube closure | GO:0001843 | 90 | 0.014 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.014 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.014 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.014 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.014 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.014 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.013 | |
| myosin filament organization | GO:0031033 | 3 | 0.013 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.013 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.013 | |
| gonad development | GO:0008406 | 141 | 0.013 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.013 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.013 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.013 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.013 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.013 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.013 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.013 | |
| regulation of protein processing | GO:0070613 | 96 | 0.013 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.013 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.013 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.013 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.013 | |
| digestive system development | GO:0055123 | 200 | 0.013 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.013 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.012 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.012 | |
| rna interference | GO:0016246 | 2 | 0.012 | |
| body fluid secretion | GO:0007589 | 53 | 0.012 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.012 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.012 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.012 | |
| ossification | GO:0001503 | 216 | 0.012 | |
| cation transport | GO:0006812 | 399 | 0.012 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.012 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.012 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.012 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.012 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.011 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.011 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.011 | |
| actin filament organization | GO:0007015 | 113 | 0.011 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.011 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.011 | |
| sensory perception | GO:0007600 | 245 | 0.011 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.011 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.011 | |
| wound healing | GO:0042060 | 157 | 0.011 | |
| regulation of cell activation | GO:0050865 | 289 | 0.011 | |
| activation of immune response | GO:0002253 | 138 | 0.011 | |
| detection of biotic stimulus | GO:0009595 | 10 | 0.011 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.011 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.011 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.011 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.011 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.011 | |
| regulation of cell size | GO:0008361 | 72 | 0.011 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.011 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.011 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.011 | |
| vesicle organization | GO:0016050 | 60 | 0.011 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.011 | |
| endocytosis | GO:0006897 | 168 | 0.010 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.010 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.010 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.010 | |
| regulation of histone modification | GO:0031056 | 56 | 0.010 | |
| protein oligomerization | GO:0051259 | 67 | 0.010 | |
| gtp catabolic process | GO:0006184 | 143 | 0.010 | |
| skeletal system development | GO:0001501 | 356 | 0.010 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.010 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.010 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.010 | |
| lipid localization | GO:0010876 | 126 | 0.010 | |
